Continuing on with our popular ‘Clinical AI – the art of the possible’ series, we are delighted to have special guest Prof Errol Norwitz, Professor of Obstetrics and Gynecology at Tufts University in Boston, speak about ‘using explainable multimodal AI in the service of pregnancy health’
With AI-driven technologies (with or without ML or LLM/Generative AI capabilities) advancing rapidly and becoming increasingly sophisticated at doing what humans do—and doing it more efficiently, more accurately, and at lower cost. Such technologies have the potential to be disruptive across the full breadth of the healthcare industry, including improving diagnosis and clinical decision-making, driving operational efficiency, and employing predictive modeling for risk stratification. Healthcare organizations that fail to maximize the technology’s promise—or fail to do so in a timely fashion—will be left behind.
In this presentation, Prof Norwitz will address the putative benefits and risks of AI-driven technologies in the field of women’s health, with specific attention to pregnancy. He will review the greatest barrier to the AI healthcare revolution, namely implementation (adoption and diffusion). To fully harness the potential of these formidable technologies, frontline care providers will need to be proficient in how to incorporate these technologies into their routine clinical workflows with a view to both improving healthcare outcomes and optimizing resource utilization (reducing cost).
Please note: This seminar will be held online and in-person at the Digital Health Validitron, Level 1, Melbourne Connect (700 Swanston Street). Please indicate your preferred attendance upon registration. Places are limited for those attending in-person.
Prof Errol Norwitz
Professor of Obstetrics and Gynecology (Ob/Gyn) at Tufts University
Errol R. Norwitz, MD, PhD, MBA is Professor of Obstetrics and Gynecology (Ob/Gyn) at Tufts University in Boston, President (Maternal Health) and Chief Innovation & Impact Officer at CognitiveCare, Inc., and a member of the Board of Scientific Counselors of NICHD. Past appointments include President & CEO of Newton-Wellesley Hospital/Mass General Brigham Healthcare System, Chief Scientific Officer at Tufts MC, and Chair of the Department of Ob/Gyn at Tufts University. He completed his medical training at University of Cape Town (South Africa), his PhD at Oxford University (as a Rhodes Scholar), his Ob/Gyn Residency and Maternal-Fetal Medicine Fellowship at Harvard, and his MBA at Questrom School of Business at Boston University. He is the author of 14 textbooks, 90 book chapters, and more than 300 original research articles/reviews. His areas of research interest include the molecular regulation of parturition, the genetics of adverse pregnancy outcomes, and the development/implementation of AI-based technologies to promote pregnancy health.
